Local environmental risk assessment of anticancer drugs in a developing country

References

• Araújo APC, Mesak C, Montalvão MF, et al. 2019. Anti-cancer drugs in aquatic environment can cause cancer: insight about mutagenicity in tadpoles. Sci Total Environ 650:2284–93. doi:10.1016/j.scitotenv.2018.09.373
   PubMed Web of Science ®Google Scholar
• Azuma T. 2018. Distribution of anticancer drugs in river waters and sediments of the Yodo River basin, Japan. Appl Sci 8:2043. doi:10.3390/app8112043
   Google Scholar
• Backhaus, T, and Faust, M. 2012. Predictive Environmental Risk Assessment of Chemical Mixtures: A Conceptual Framework. Environ Sci Technol 46:2564–73 doi: 10.1021/es2034125
   PubMed Web of Science ®Google Scholar
• Backhaus T, Scholze M, and Grimme LH. 2000. The single substance and mixture toxicity of quinolones to the bioluminescent bacterium Vibrio fischeri. Aquat Toxicol 49:49–61. doi:10.1016/S0166-445X(99)00069-7
   PubMed Web of Science ®Google Scholar
• Batt AL, Furlong ET, Mash HE, et al. 2017. The importance of quality control in validating concentrations of contaminants of emerging concern in source and treated drinking water samples. Sci Total Environ 579:1618–28. doi:10.1016/j.scitotenv.2016.02.127
   PubMed Web of Science ®Google Scholar
• Bertrand-Krajewski J-L. 2018. Pharmaceuticals and detergents in hospital and urban wastewater: comparative monitoring, treatment, and assessment of impacts. Environ Sci Pollut Res 25:9195–6. doi:10.1007/s11356-018-1445-0
   PubMed Web of Science ®Google Scholar
• Besse J-P, Kausch-Barreto C, and Garric J. 2008. Exposure assessment of pharmaceuticals and their metabolites in the aquatic environment: application to the French situation and preliminary prioritization. Hum Ecol Risk Assess 14:665–95. doi:10.1080/10807030802235078
   Web of Science ®Google Scholar
• Białk-Bielińska A, Mulkiewicz E, Stokowski M, et al. 2017. Acute aquatic toxicity assessment of six anti-cancer drugs and one metabolite using biotest battery—biological effects and stability under test conditions. Chemosphere 189:689–98. doi:10.1016/j.chemosphere.2017.08.174
   PubMed Web of Science ®Google Scholar
• Bittencourt S, Aisse MM, Serrat BM, et al. 2016. Sorção de Poluentes Orgânicos Emergentes Em Lodo de Esgoto. Eng Sanit Ambient 21:43–53. doi:10.1590/s1413-41520201600100119334
   Web of Science ®Google Scholar
• Booker V, Halsall C, Llewellyn N, et al. 2014. Prioritising anticancer drugs for environmental monitoring and risk assessment purposes. Sci Total Environ 473–474:159–70. doi:10.1016/j.scitotenv.2013.11.145
   PubMed Web of Science ®Google Scholar
• Brezovšek P, Eleršek T, and Filipič M. 2014. Toxicities of four anti-neoplastic drugs and their binary mixtures tested on the green alga Pseudokirchneriella subcapitata and the cyanobacterium Synechococcus leopoliensis. Water Res 52:168–77. doi:10.1016/j.watres.2014.01.007
   PubMed Web of Science ®Google Scholar
• Buerge IJ, Buser HR, Poiger T, et al. 2006. Occurrence and fate of the cytostatic drugs cyclophosphamide and ifosfamide in wastewater and surface waters. Environ Sci Technol 40:7242–50. doi:10.1021/es0609405
   PubMed Web of Science ®Google Scholar
• Burns EE, Carter LJ, Snape J, et al. 2018. Application of prioritization approaches to optimize environmental monitoring and testing of pharmaceuticals. J Toxicol Environ Health B: Crit Rev 21:115–41. doi:10.1080/10937404.2018.1465873
   PubMed Web of Science ®Google Scholar
• Česen M, Eleršek T, Novak M, et al. 2016. Ecotoxicity and genotoxicity of cyclophospamide, ifosfamide, their metabolites/transformation products and their mixtures. Environ Pollut 210:192–201. doi:10.1016/j.envpol.2015.12.017
   PubMed Web of Science ®Google Scholar
• Daouk S, Chèvre N, Vernaz N, et al. 2015. Prioritization methodology for the monitoring of active pharmaceutical ingredients in hospital effluents. J Environ Manag 160:324–32. doi:10.1016/j.jenvman.2015.06.037
   PubMed Web of Science ®Google Scholar
• Departamento de informática do Sistema Único de Saúde (DATASUS). 2018. Data Health. http://datasus.saude.gov.br/informacoes-de-saude/tabnet/assistencia-a-saude
   Google Scholar
• DeYoung DJ, Bantle JA, Hull MA, et al. 1996. Differences in sensitivity to developmental toxicants as seen in Xenopus and Pimephales embryos. Bull Environ Contam Toxicol 56:143–50. doi:10.1007/s001289900021
   PubMed Web of Science ®Google Scholar
• Egeler P, and Seck C. 2008. 5-Fluorouracil: A study on the toxicity to early-life stages of Danio rerio (zebrafish). ECT Oekotoxicologie. Flörsheim/Main (DE) and Battelle UK, Ongar (UK) Report nr. ECT 08AZ1FV 
   Google Scholar
• Ehninger G, Proksch B, and Schiller E. 1985. Detection and separation of mitoxantrone and its metabolites in plasma and urine by highperformance liquid chromatography. J Chromatogr Biomed Appl 342:119–127
   Google Scholar
• Elersek T, Milavec S, Korošec M, et al. 2016. Toxicity of the mixture of selected antineoplastic drugs against aquatic primary producers. Environ Sci Pollut Res 23:14780–90. doi:10.1007/s11356-015-6005-2
   PubMed Web of Science ®Google Scholar
• EMEA. 2006. Guideline on the Environmental Risk Assessment of Medicinal Products for Human Use. EMEA, London
   Google Scholar
• Ferrando-Climent L, Rodriguez-Mozaz S, and Barceló D. 2014. Incidence of anticancer drugs in an aquatic urban system: from hospital effluents through urban wastewater to natural environment. Environ Pollut 193:216–23. doi:10.1016/j.envpol.2014.07.002
   PubMed Web of Science ®Google Scholar
• Franquet-Griell H, Gómez-Canela C, Ventura F, et al. 2015. Predicting concentrations of cytostatic drugs in sewage effluents and surface waters of Catalonia (NE Spain). Environ Res 138:161–72. doi:10.1016/j.envres.2015.02.015
   PubMed Web of Science ®Google Scholar
• Ghafuri Y, Yunesian M, Nabizadeh R, et al. 2018. Platinum cytotoxic drugs in the municipal wastewater and drinking water, a validation method and health risk assessment. Hum Ecol Risk Assess 24:784–96. doi:10.1080/10807039.2017.1400372
   Web of Science ®Google Scholar
• Gómez-Canela C, Campos B, Barata C, et al. 2015. Degradation and toxicity of mitoxantrone and chlorambucil in water. Int J Environ Sci Technol 12:633–40. doi:10.1007/s13762-013-0454-2
   Web of Science ®Google Scholar
• Gómez-Canela C, Ventura F, Caixach J, et al. 2014. Occurrence of cytostatic compounds in hospital effluents and wastewaters, determined by liquid chromatography coupled to high-resolution mass spectrometry. Anal Bioanal Chem 406:3801–14. doi:10.1007/s00216-014-7805-9
   PubMed Web of Science ®Google Scholar
• Gu G, Yin H, Zhu Q, et al. 2018. Recognition of the prioritized types and individual of pharmaceuticals and personal care products (PPCPs) in the drinking water of Shanghai and a health risk assessment. Hum Ecol Risk Assess 25:1207–21. doi:10.1080/10807039.2018.1461009
   Web of Science ®Google Scholar
• Guzel EY, Cevik F, and Daglioglu N. 2018. Determination of pharmaceutical active compounds in Ceyhan River, Turkey: seasonal, spatial variations and environmental risk assessment. Hum Ecol Risk Assess Int J. 24: 1-16. doi:10.1080/10807039.2018.1479631
   Web of Science ®Google Scholar
• Helwig K, Hunter C, MacLachlan J, et al. 2013. Micropollutant point sources in the built environment: identification and monitoring of priority pharmaceutical substances in hospital effluents. J Environ Anal Toxicol 3:1–10. doi:10.4172/2161-0525.1000177
   Google Scholar
• Henschel KP, Wenzel A, Diedrich M, et al. 1997. Environmental hazard assessment of pharmaceuticals. Regul Toxicol Pharmacol 25:220–5. doi:10.1006/rtph.1997.1102
   PubMed Web of Science ®Google Scholar
• Instituto Trata Brasil. 2018. National Sanitation Ranking. Instituto Trata Brasil, São Paulo. http://www.tratabrasil.org.br/images/estudos/itb/ranking-2018/realatorio-completo.pdf
   Google Scholar
• Isidori M, Lavorgna M, Russo C, et al. 2016. Chemical and toxicological characterisation of anticancer drugs in hospital and municipal wastewaters from Slovenia and Spain. Environ Pollut 219:275–87. doi:10.1016/j.envpol.2016.10.039
   PubMed Web of Science ®Google Scholar
• Joss A, Zabczynski S, Göbel A, et al. 2006. Biological degradation of pharmaceuticals in municipal wastewater treatment: proposing a classification scheme. Water Res 40:1686–96. doi:10.1016/j.watres.2006.02.014
   PubMed Web of Science ®Google Scholar
• Jureczko M and Przystaś W. 2019. Ecotoxicity risk of presence of two cytostatic drugs: bleomycin and vincristine and their binary mixture in aquatic environment. Ecotoxicol Environ Saf 172:210–5. doi:10.1016/j.ecoenv.2019.01.074
   PubMed Web of Science ®Google Scholar
• Kiffmeyer T, Götze H-J, Jursch M, et al. 1998. Trace enrichment, chromatographic separation and biodegradation of cytostatic compounds in surface water. Fresenius’ J Anal Chem 361:185–91. doi:10.1007/s002160050859
   Google Scholar
• Kosjek T and Heath E. 2011. Occurrence, fate and determination of cytostatic pharmaceuticals in the environment. Trends Anal Chem 30:1065–87. doi:10.1016/j.trac.2011.04.007
   Web of Science ®Google Scholar
• Kovács R, Bakos K, Urbányi B, et al. 2016. Acute and sub-chronic toxicity of four cytostatic drugs in zebrafish. Environ Sci Pollut Res 23:14718–29. doi:10.1007/s11356-015-5036-z
   PubMed Web of Science ®Google Scholar
• Kümmerer K and Al-Ahmad A. 1997. Biodegradability of the anti-tumour agents 5-fluorouracil, cytarabine, and gemcitabine: impact of the chemical structure and synergistic toxicity with hospital effluent. Acta Hydrochim Hydrobiol 25:166–72. doi:10.1002/aheh.19970250402
   Google Scholar
• Kümmerer K, Haiß A, Schuster A, et al. 2016. Antineoplastic compounds in the environment—substances of special concern. Environ Sci Pollut Res 23:14791–804. doi:10.1007/s11356-014-3902-8
   PubMed Web of Science ®Google Scholar
• Kundi, M, Parrella, A, Lavorgna, M, et al. 2016. Prediction and assessment of ecogenotoxicity of antineoplastic drugs in binary mixtures. Environ Sci Pollut Res 23:14771–9 doi: 10.1007/s11356-015-4884-x
   PubMed Web of Science ®Google Scholar
• Laquaz M, Dagot C, Bazin C, et al. 2018. Ecotoxicity and antibiotic resistance of a mixture of hospital and urban sewage in a wastewater treatment plant. Environ Sci Pollut Res 25:9243–53. doi:10.1007/s11356-017-9957-6
   PubMed Web of Science ®Google Scholar
• Lenz K, Hann S, Koellensperger G, et al. 2005. Presence of cancerostatic platinum compounds in hospital wastewater and possible elimination by adsorption to activated sludge. Sci Total Environ 345:141–52. doi:10.1016/j.scitotenv.2004.11.007
   PubMed Web of Science ®Google Scholar
• Lenz K, Koellensperger G, Hann S, et al. 2007. Fate of cancerostatic platinum compounds in biological wastewater treatment of hospital effluents. Chemosphere 69:1765–74. doi:10.1016/j.chemosphere.2007.05.062
   PubMed Web of Science ®Google Scholar
• Li Z, Xiang X, Li M, et al. 2015. Occurrence and risk assessment of pharmaceuticals and personal care products and endocrine disrupting chemicals in reclaimed water and receiving groundwater in China. Ecotoxicol Environ Saf 119:74–80. doi:10.1016/j.ecoenv.2015.04.031
   PubMed Web of Science ®Google Scholar
• Link M, von der Ohe PC, Voß K, et al. 2017. Comparison of dilution factors for german wastewater treatment plant effluents in receiving streams to the fixed dilution factor from chemical risk assessment. Sci Total Environ 598:805–13. doi:10.1016/j.scitotenv.2017.04.180
   PubMed Web of Science ®Google Scholar
• Mahnik SN, Lenz K, Weissenbacher N, et al. 2007. Fate of 5-fluorouracil, doxorubicin, epirubicin, and daunorubicin in hospital wastewater and their elimination by activated sludge and treatment in a membrane-bio-reactor system. Chemosphere 66:30–7. doi:10.1016/j.chemosphere.2006.05.051
   PubMed Web of Science ®Google Scholar
• Mahnik SN, Rizovski B, Fuerhacker M, et al. 2006. Development of an analytical method for the determination of anthracyclines in hospital effluents. Chemosphere 65:1419–25. doi:10.1016/j.chemosphere.2006.03.069
   PubMed Web of Science ®Google Scholar
• Márta Z, Bobály B, Fekete J, et al. 2018. Simultaneous determination of thirteen different steroid hormones using micro UHPLC-MS/MS with on-line SPE system. J Pharm Biomed Anal 150:258–67. doi:10.1016/j.jpba.2017.12.014
   PubMed Web of Science ®Google Scholar
• Martín J, Camacho-Munõz D, Santos JL, et al. 2014. Occurrence and ecotoxicological risk assessment of 14 cytostatic drugs in wastewater. Water Air Soil Pollut 225:1896. doi:10.1007/s11270-014-1896-y
   Web of Science ®Google Scholar
• Mastroianni N, Bleda MJ, de Alda ML, et al. 2016. Occurrence of drugs of abuse in surface water from four Spanish river basins: spatial and temporal variations and environmental risk assessment. J Hazard Mater 316:134–42. doi:10.1016/j.jhazmat.2016.05.025
   PubMed Web of Science ®Google Scholar
• Mendoza A, Aceña J, Pérez S, et al. 2015. Pharmaceuticals and iodinated contrast media in a hospital wastewater: a case study to analyse their presence and characterise their environmental risk and hazard. Environ Res 140:225–41
   PubMed Web of Science ®Google Scholar
• Moermond, C T, Kase, R, Korkaric, M, and Ågerstrand, M. 2016. CRED: Criteria for reporting and evaluating ecotoxicity data. Environ Toxicol Chem 35:1297–309 doi: 10.1002/etc.3259
   PubMed Web of Science ®Google Scholar
• Ministry of Health Brazil. 2013. Portaria No. 874, De 16 De Maio De 2013. http://bvsms.saude.gov.br/bvs/saudelegis/gm/2013/prt0874_16_05_2013.html
   Google Scholar
• Moermond C, Venhuis B, van Elk M, et al. 2018. Cytostatics in Dutch Surface Water. National Institute for Public Health and the Environment, The Netherlands. doi:10.21945/RIVM-2018-0067.
   Google Scholar
• Negreira N, de Alda ML, and Barceló D. 2014. Study of the stability of 26 cytostatic drugs and metabolites in wastewater under different conditions. Sci Total Environ 482–483:389–98. doi:10.1016/j.scitotenv.2014.02.131
   PubMed Web of Science ®Google Scholar
• Nidumolu, B., Kumar, A., 2012. Effect assessment of pharmaceuticals using the aquaticplant, Lemna minor. 2nd SETAC Australasia Conference, Brisbane.
   Google Scholar
• Olalla A, Negreira N, de Alda ML, et al. 2018. A case study to identify priority cytostatic contaminants in hospital effluents. Chemosphere 190:417–30. doi:10.1016/j.chemosphere.2017.09.129
   PubMed Web of Science ®Google Scholar
• Parrella A, Lavorgna M, Criscuolo E, et al. 2014. Acute and chronic toxicity of six anticancer drugs on rotifers and crustaceans. Chemosphere 115:59–66. doi:10.1016/j.chemosphere.2014.01.013
   PubMed Web of Science ®Google Scholar
• Riva F, Castiglioni S, Fattore E, et al. 2018. Monitoring emerging contaminants in the drinking water of Milan and assessment of the human risk. Int J Hyg Environ Health 221:451–7. doi:10.1016/j.ijheh.2018.01.008
   PubMed Web of Science ®Google Scholar
• Rowney NC, Johnson AC, and Williams RJ. 2009. Pharmaceuticals and personal care products in the environment. Cytotoxic drugs in drinking water: a prediction and risk assessment exercise for the Thames catchment in the United Kingdom. Environ Toxicol Chem 28:2733–43
   PubMed Web of Science ®Google Scholar
• Russo C, Lavorgna M, Česen M, et al. 2018. Evaluation of acute and chronic ecotoxicity of cyclophosphamide, ifosfamide, their metabolites/transformation products and UV treated samples. Environ Pollut 233:356–63. doi:10.1016/j.envpol.2017.10.066
   PubMed Web of Science ®Google Scholar
• Santos MSF, Franquet-Griell H, Lacorte S, et al. 2017. Anticancer drugs in Portuguese surface waters—estimation of concentrations and identification of potentially priority drugs. Chemosphere 184:1250–60. doi:10.1016/j.chemosphere.2017.06.102
   PubMed Web of Science ®Google Scholar
• SCHER, SCCS, SCENIHR. 2012. Opinion on the Toxicity and Assessment of Chemical Mixtures. Toxicity and Assessment of Chemical Mixtures. http://ec.europa.eu/health/scientific_committees/consultations/public_consultations/scher_consultation_06_en.htm
   Google Scholar
• Silva RF, de Lima Moura L, Gavião LO, et al. 2018. Evaluation of the potential contamination of water with oncological drugs in municipalities of Brazil’s south region. Rev Gest Sust Ambient 7:275–99
   Google Scholar
• SNIS, Sistema Nacional De Informações Sobre Saneamento. 2018. http:/www.snis.gov.br/aplicacao-web-serie-historica
   Google Scholar
• Souza FS and Féris LA. 2017. Consumption-based approach for pharmaceutical compounds in a large hospital. Environ Technol 38:2217–23. doi:10.1080/09593330.2016.1255262
   PubMed Web of Science ®Google Scholar
• Steger-Hartmann T, Kümmerer K, and Hartmann A. 1997. Biological degradation of cyclophosphamide and its occurrence in sewage water. Ecotoxicol Environ Saf 36:174–9. doi:10.1006/eesa.1996.1506
   PubMed Web of Science ®Google Scholar
• Straub JO. 2010. Combined environmental risk assessment for 5-fluorouracil and capecitabine in Europe. Integr Environ Assess Manag 6:540–66. doi:10.1897/IEAM
   PubMedGoogle Scholar
• Suárez S, Carballa M, Omil F, et al. 2008. How are pharmaceutical and personal care products (PPCPs) removed from urban wastewaters? Rev Environ Sci Biotechnol 7:125–38. doi:10.1007/s11157-008-9130-2
   Google Scholar
• TGD. 2003. Technical Guidance Document on Risk Assessment. Part II. ISPRA, Italy. doi:10.1002/mp.12308
   Google Scholar
• TOXNET, Toxicology Data Network. 2018. Docetaxel Data. https://toxnet.nlm.nih.gov/cgi-bin/sis/search2
   Google Scholar
• United States, Environmental Protection, and Agency (USEPA). 2012. About This Document. Sustainable Futures/P2 Framework P2 Framework Manual. USEPA, Washington, DC, USA. doi:10.3186/jjphytopath.49.727
   Google Scholar
• Verlicchi P and Zambello E. 2015. Pharmaceuticals and personal care products in untreated and treated sewage sludge: occurrence and environmental risk in the case of application on soil—a critical review. Sci Total Environ 538:750–67. doi:10.1016/j.scitotenv.2015.08.108
   PubMed Web of Science ®Google Scholar
• Weigt S, Huebler N, Strecker R, et al. 2011. Zebrafish (Danio rerio) embryos as a model for testing proteratogens. Toxicology 281:25–36. doi:10.1016/j.tox.2011.01.004
   PubMed Web of Science ®Google Scholar
• Whomsley R, Brendler-Schwaab S, Griffin E, et al. 2019. Commentary on the draft revised guideline on the environmental risk assessment of medicinal products for human use. Environ Sci Eur 31:17
   Web of Science ®Google Scholar
• Xie H. 2012. Occurrence, ecotoxicology, and treatment of anticancer agents as water contaminants. J Environ Anal Toxicol 2:1–11. doi:10.4172/2161-0525.s2-002
   Google Scholar
• Załęska-Radziwiłł M, Affek K, and Doskocz N. 2017. Ecotoxicological risk assessment of chosen pharmaceuticals detected in surface waters. J Environ Sci Health A: Toxic/Hazard Subst Environ Eng 52:1233–9. doi:10.1080/10934529.2017.1356199
   PubMed Web of Science ®Google Scholar
• Zhang J, Chang VW, Giannis A, et al. 2013. Removal of cytostatic drugs from aquatic environment: a review. Sci Total Environ 445–446:281–98. doi:10.1016/j.scitotenv.2012.12.061
   PubMed Web of Science ®Google Scholar
• Zounkova R, Kovalova L, Blaha L, et al. 2010. Ecotoxicity and genotoxicity assessment of cytotoxic antineoplastic drugs and their metabolites. Chemosphere 81:253–60. doi:10.1016/j.chemosphere.2010.06.029
   PubMed Web of Science ®Google Scholar
• Zounková R, Odraska P, Dolezalova L, et al. 2007. Ecotoxicity and genotoxicity assessment of cytostatic pharmaceuticals. Environ Toxicol Chem 26:2208–14. doi:10.1109/WPMC.2017.8301891
   PubMed Web of Science ®Google Scholar